AXGN Stock Analysis: Buy, Sell, or Hold?
AXGN - Axogen, Inc. Common Stock
Get Alerted When AXGN Hits Your Target Price
Join 10,000+ traders who never miss a move
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading historical data...
π HOLD: AXGN is fairly valued with market pricing in 4.2% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Technical Outlook: Technically, AXGN is in a strong uptrend. The price is approaching resistance at $35.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AXGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Protect Your Profits
Holding AXGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($37.00)
- NEUTRAL: Market pricing in 4.2% annual earnings growth - fairly valued
Fair Price Analysis
Support & Resistance Levels
Fundamental Context
Data refreshes hourly during market hours. Next update: 7:34 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Is AXGN showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
Advanced AXGN Option Strategies
Professional options setups generated by AI based on today's AXGN price and gamma walls.